Back to search
FDAFDA · Food and drugs·Recall number D-1378-2012

CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.

Published June 20, 2012 · Recall initiated: March 15, 2011

Summary

FDA records drug Class II recall D-1378-2012, published June 20, 2012 and initiated March 15, 2011. Recalling firm: Luitpold Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 30 mL: 2,078,800 vials; 100 mL: 167,100 vials; Lot: 30 mL Lots: 9198, 9252, 9299, 9305, 9402, 9423, 9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095, 0362; 100 mL Lots: 9225, 9492, 9711, 0007, 0058. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Luitpold Pharmaceuticals, Inc.
Distributor
Nationwide, Puerto Rico, and Abu Dhabi
Lot
30 mL Lots: 9198, 9252, 9299, 9305, 9402, 9423, 9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095, 0362; 100 mL Lots: 9225, 9492, 9711, 0007, 0058
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967. recalled?

Yes. FDA published recall D-1378-2012 on June 20, 2012. Reported hazard: Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release